Skip to main content
. 2014 May;11(4):357–366. doi: 10.2174/1567205011666140317101419

Table 2.

aseline Characteristics of the PLASA Cohort Included in Analyses, N=734

Variable Mean (SD)
Age 79.30 (5.60)
Time since symptom onset (years) 3.55 (2.67)
Time since AD diagnosis (years) 1.32 (1.63)
MMSE 19.83 (3.97)
Total ADCS-ADL 54.46 (14.84)
  N (%)
Female 538 (73.30)
Education

  • Primary school or less

  • Certificate

  • Middle School

  • High school or more

   192 (26.23)
294 (40.16)
141 (19.26)
105 (14.34)
Living Situation

  • Alone

  • With spouse

  • With family/Other

   248 (33.79)
382 (52.04)
104 (14.17)
Comorbidities (present)

  • Hypercholesterolemia

  • Hypertension

  • Depression

   244 (33.38)
347 (47.34)
287 (39.26)
Medications

  • Taking Alzheimer’s treatments

(acetylcholinesterase inhibitors and/or memantine)

  • Taking <3 concomitant prescription meds

  • Taking >3 concomitant prescription meds

   575 (78.34) 346 (47.14)
388 (52.86)